CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Estimation of P.Gingivalis levels +1 moregenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02503046
NCT02503046N/ACompleted
CompareCT.gov

Estimation of Pentraxin 3 and Porphyromonas Gingivalis Levels in Patients With Rheumatoid Arthritis and Periodontitis- An Observational Study

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre·observational·Posted Jul 20, 2015·Updated Aug 29, 2016

In Brief

An observational study evaluating Estimation of Pentraxin3 and Estimation of P.Gingivalis levels for Rheumatoid Arthritis and Chronic Periodontitis. Completed, enrolled 90 participants across 1 site.

Detailed Summary

Periodontitis and Rhematoid arthritis are chronic inflammatory diseases which share common risk factors The purpose of this study is to determine if Pentraxin 3 and Porphyromonas Gingivalis levels play an important role in the progression of both the diseases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis, Chronic Periodontitis
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 20, 2015
Enrollment StartFeb 1, 2015
Primary CompletionNov 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.0 years ago

Interventions

Estimation of Pentraxin3other

5ml of blood to be collected from each subject, centrifuged, to separate the plasma for estimation of Pentraxin3 (Quantikine ELISA)

Estimation of P.Gingivalis levelsgenetic

Pooled plaque sample will be collected and sent for DNA Extraction by PCR for assessment of levels of PGingivalis